Key Takeaways:
Hyperliquid Strategies expanded its equity financing facility with Chardan Capital Markets to $2.5 billion on Sept. 1, adding $1.5 billion of capacity earmarked for potential HYPE purchases.
The Nasdaq-listed treasury company, trading under PURR, disclosed the change in a Form 8-K filed with the U.S. Securities and Exchange Commission. Its prospectus lists potential purchases of HYPE, the native token of the Hyperliquid network, among the general corporate purposes that proceeds could support.
The $2.5 billion figure is the facility's maximum aggregate capacity, not an amount received or committed to token buys. Each sale of newly issued shares to Chardan increases PURR's outstanding count, diluting existing investors. Hyperliquid Strategies controls the timing and size of individual sales, with its disclosures tying financing decisions to market conditions and PURR's trading price.
The expansion extends the runway of a token-accumulation strategy that has already spent $773.4 million for about 16.5 million HYPE tokens at an average $46.77, lifting holdings to 29.3 million tokens as of Aug. 19. The company reported $149.9 million in cash at the end of June and no debt.
Exchange cap binds below $12.02
The amendment, signed as Amendment No. 1 to the ChEF Purchase Agreement dated Oct. 22, 2025, introduces a Nasdaq exchange cap that takes effect after aggregate sales through the facility reach $1 billion. Beyond that threshold, Hyperliquid Strategies generally cannot sell more than 42,641,847 shares at prices below $12.02, equal to 19.99 percent of common shares outstanding before the amendment. At $12.02, that share count represents about $512.5 million in gross proceeds.
The company can exceed the cap if shareholders approve additional issuance under Nasdaq rules, or if approval is not required under an applicable provision. The restriction means raising the full $2.5 billion may require higher sale prices, shareholder approval or a Nasdaq exception when PURR trades below $12.02.
PURR closes below the threshold
PURR closed at $11.36 on Sept. 1, down 7.3 percent during regular trading, after opening at $11.76 and trading between $11.03 and $12.31 on volume of about 24.3 million shares. The close put the stock below the amendment's $12.02 reference level, though the market price alone does not trigger the cap, which concerns completed below-threshold sales after cumulative facility purchases reach $1 billion.
The company had already drawn heavily on the original $1 billion line. During the fiscal year ended June 30, it raised $647 million through PURR issuance, selling 76.1 million shares at an average net price of $8.50. Its HYPE stake, marked at $65.04 per token on June 30, was worth about $1.9 billion; at HYPE's $83.30 price as of Sept. 2, the position is worth roughly $2.44 billion, per CoinGecko data.
The facility differs from a loan, since selling shares creates no principal repayments or interest but exchanges equity for cash. Whether the added capacity is drawn, and whether proceeds go to HYPE rather than operating costs, depends on later purchase notices, market prices and the exchange-cap condition. The company also runs a $30 million buyback program authorized in December 2025, of which about $28 million had been deployed through mid-August.
This article is for informational purposes only and does not constitute investment advice.
